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Abstract
After the introduction of highly active antiretroviral therapies (HAART), an increased incidence of insulin resistance, 
diabetes mellitus (DM), and cardiovascular diseases has been described. The impact of such conditions on mortality in 
the post-HAART era has been also assessed in various modes in the literature. In this paper, we report on the death risks 
for DM, myocardial infarction, and chronic ischemic heart diseases that were investigated among 9662 Italian AIDS 
cases diagnosed between 1999 and 2005. Death certificates reporting DM, myocardial infarction, and chronic ischemic 
heart diseases were reviewed to identify the underlying cause of death, and to compare the observed numbers of 
deaths with the expected ones from the sex- and age-matched, general population of Italy. Person-years at risk of 
death were computed from date of AIDS diagnosis up to date of death or to December 31, 2006. Standardized 
mortality ratios (SMR) and their 95% confidence intervals (CI) were computed. DM and cardiovascular diseases were the 
cause of death for 43 out of 3101 deceased AIDS cases (i.e., 1.4% of all deaths). In comparison with the general 
population, the risks of death were 6.4-fold higher for DM (95% CI:3.5-10.8), 2.3-fold higher for myocardial infarction 
(95% CI:1.4-3.7) and 3.0 for chronic ischemic heart diseases (95% CI: 1.5-5.2).
Findings
HIV-infected people are at increasing risk of developing
several non-AIDS defining illnesses, including diabetes
mellitus (DM) and cardiovascular diseases [1-3]. Tradi-
tional risk factors (such as cigarette smoking, ageing, obe-
sity, and viral co-infections) and duration of HIV
infection are considered responsible of their elevated fre-
q u e n c y ,  t h o u g h  t h e y  h a v e  a l s o  b e e n  a s s o c i a t e d  w i t h
adverse effects of antiretroviral treatments [1,4-6]. Sev-
eral studies have evaluated the incidence of DM and car-
diovascular diseases in HIV-infected persons in the era of
highly active antiretroviral therapies (HAART), and their
impact as causes of death [7-10].
By taking advantage of the population-based data used
for assessing post-AIDS survival [11], we estimated the
risk of death for DM, myocardial infarction, and chronic
ischemic heart diseases among people with AIDS diag-
nosed between 1999 and 2005. The original study design
and the main characteristics of study subjects were previ-
ously described [11]. Briefly, in Italy AIDS cases are diag-
nosed according to the 1993 revised European AIDS
definition [12], and they are compulsorily reported to the
national AIDS registry (RNAIDS), a comprehensive sur-
veillance system formerly described in detail [13]. Under-
reporting of people with AIDS (PWA) has been estimated
at about 5% [14], whereas the vital status of PWA is not
routinely kept up-to-date. The updated vital status of
PWA was sought for in the Italian Mortality Database at
the Italian National Institute of Statistics through a
record linkage procedure. Data regarding PWA diag-
nosed in Italy from 1999 and 2005 were linked with data
concerning the 4,420,498 deaths occurred between 1999
and 2006. After excluding non Italian citizens, pediatric
cases, PWA diagnosed solely at autopsy who were resi-
dents in provinces where information on names were not
available on deaths certificates, 9662 Italian adult PWA
constituted the study population. Of these PWA, 3101
died. Conditions listed in the death certificate were classi-
fied as AIDS- or non-AIDS-related based on the pres-
ence/absence of an AIDS-defining condition according to
the 1993 revised European AIDS definition [12].
Deaths certificates reporting DM, myocardial infarc-
tion, and chronic ischemic heart diseases in any position
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were reviewed by study members to distinguish when one
of these conditions was the underlying cause of death
(i.e., the disease which initiated the sequence of morbid
events leading directly to death) or a contributing one.
This process was undertaken to properly compare the
observed numbers of DM, myocardial infarction, and
chronic ischemic heart diseases as underlying cause of
death in PWA with the expected numbers from the sex-
and age-matched, general population of Italy. The codifi-
cation rules of the International Classification of Dis-
eases, tenth revision (ICD-10), were applied.
We took into consideration all ICD-10 codes pertaining
to DM (i.e., E10-E14), while for cardiovascular causes of
death, we focused on acute myocardial infarction (ICD-
10, I21) and chronic ischemic heart diseases (ICD-10,
I25), two important and well diagnosed conditions.
Person-years (PY) at risk of death were computed from
date of AIDS diagnosis up to date of death or to Decem-
ber 31, 2006. The number of observed deaths due to DM,
myocardial infarction, or chronic ischemic heart diseases
was divided by the expected one, computed from age and
sex specific mortality rates from the Italian general popu-
lation in the same period. Thus, standardized mortality
ratios (SMR) and their 95% confidence intervals (CI) were
computed [15].
The 9,662 AIDS cases included in this study summed
up to 34,814 PY of follow-up and 3,101 deaths. The most
frequent conditions listed in death certificates were
hepatic diseases (reported in 31.0% of death certificates),
AIDS-associated opportunistic infections (29.2%), other
infectious diseases not included in the AIDS definition
(24.1%), non-Hodgkin lymphoma (14.6%), and Kaposi
sarcoma (4.3%) (data not shown).
DM and cardiovascular diseases were the underlying
cause of death of 43 PWA (i.e., they cause 1.4% of all
deaths): 14 deaths were caused by DM, 17 by myocardial
infarction, and 12 by chronic ischemic heart diseases
Table 1. The corresponding SMR were 6.4 for DM (95%
CI:3.5-10.8), 2.3 for myocardial infarction (95% CI:1.4-
3.7) and 3.0 for chronic ischemic heart diseases (95% CI:
1.5-5.2).
T h e  r i s k  o f  d e a t h  a s s o c i a t e d  t o  D M  w a s  m o r e  p r o -
nounced in younger (SMR = 13.8) than in older individu-
als (SMR = 4.9), and it was restricted to men Table 1. An
18-fold higher risk of death for DM was seen among
intravenous drug users (IDUs). The risks of death associ-
ated with myocardial infarction and with chronic isch-
emic heart diseases were substantially elevated in women
(SMR = 9.9 and SMR = 14.9, respectively), whereas they
were of borderline statistical significance in men. A par-
ticularly pronounced excess risk was seen for chronic
ischemic heart diseases in cases aged less than 45 years at
AIDS diagnosis (SMR = 7.8) Table 1. The SMR for
chronic ischemic heart diseases was nearly 10-fold higher
in IDUs than in the general population Table 1
DM, myocardial infarction, and chronic ischemic heart
diseases had a marginal impact (i.e., 1.4%) on mortality of
Italian AIDS cases in the post-HAART era. However, the
risks of death were remarkably higher than in the corre-
sponding general population. We have used mortality
rates in the general population as a bench mark for com-
parison, because the overall mortality of HIV-infected
individuals is increasingly influenced by deaths that
would have occurred regardless of HIV infection.
Although based on small numbers, differences in the
magnitude of SMRs according to sex, age and HIV-trans-
mission category seem to point toward multiple risk fac-
tors (e.g., smoking for cardiovascular diseases). We have
previously demonstrated, among Italian AIDS cases
below the age of 55 years, a nearly 5-fold excess death risk
for pancreatic cancer [16]. Such observation is in line
with the well established role of DM as a risk factor for
pancreatic cancer [17]. With regard to myocardial infarc-
tion and ischemic heart diseases, the patterns of risk
herein described seem to resemble the one seen, in HIV-
infected persons, for smoking-related cancers. Our group
has recently shown, in Italian AIDS cases, a 4-fold higher
risk in men and a 6-fold higher risk in women of develop-
ing lung cancer, an excess risk mainly attributed to a high
prevalence of smokers in HIV-infected people [18]. As for
lung cancer, HIV-infected people are likely to be at higher
risk for other smoking-related diseases, because such a
habit is more common among them than in the general
population.
Possible limitations of this study should be addressed.
With regard to the identification of the underlying cause
of death, we adopted the same ICD-10 rules of codifica-
tion used by the Italian National Institute of Statistics for
the general population (i.e., without considering the men-
tion of HIV/AIDS). We acknowledge that the quality of
death certificates is low and that the ICD-10 rules may be
of difficult application to people with severe immunode-
ficiency, given that these people are at risk of dying from
a multitude of other causes. From a statistical viewpoint,
the stratified analyses suffered from the small numbers of
observed deaths in several subgroups, whereas the analy-
sis regarding the total number of deaths allowed us a finer
computation of SMR. Furthermore, the dataset used for
this analysis did not include information on individual
r i s k  f a c t o r s ;  w e  w e r e ,  t h u s ,  u n a b l e  t o  p r o v i d e  f u r t h e r
insights in the reasons for this excess risk. Conversely,
completeness was the main advantage of population-
based investigations, and for this analysis, we used two
databases covering the whole Italian population.
In conclusion, DM and cardiovascular diseases caused
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Table 1: Standardized mortality ratios of dying from diabetes mellitus, myocardial infarction, or chronic ischemic heart 
diseases in people with AIDS, according to selected characteristics. Italy, 1999-2006
Cause of death
Diabetes mellitus Myocardial infarction Chronic ischemic heart diseases
PY Obs Exp SMR
(95% CI)
Obs Exp SMR
(95% CI)
Obs Exp SMR
(95% CI)
Age at AIDS diagnosis
(n° of cases)
<45 (6958) 26389 5 0.36 13.8
(4.4-32)
4 1.97 2.0
(0.5-5.2)
40 . 5 17 . 8
(2.0-20)
≥45 (2704) 8425 9 1.82 4.9
(2.2-9.4)
13 5.34 2.4
(1.3-4.2)
83 . 5 02 . 3
(1.0-4.5)
Sex (n° of cases)
Male (7511) 26962 14 1.97 7.1
(3.9-11.9)
14 7.01 2.0
(1.1-3.4)
93 . 8 12 . 4
(1.1-4.5)
Female (2151) 7851 0 0.21 0 3 0.30 9.9
(1.9-29)
30 . 2 0 1 4 . 9
(2.8-44)
HIV-transmission 
category (n° of cases)
Intravenous drug user 
(4040)
14235 5 0.28 18.2
(5.7-43)
5 1.42 3.5
(1.1-8.3)
40 . 4 19 . 7
(2.5-25)
Homosexual man 
(1741)
6512 2 0.61 3.3
(0.3-12.1)
0 2.08 0 3 1.14 2.6
(0.5-7.8)
Heterosexual (3297) 12121 5 1.06 4.7
(1.5-11.1)
10 3.14 3.2
(1.5-5.9)
31 . 9 91 . 5
(0.3-4.5)
Other (584) 1945 2 0.24 8.5
(0.8-31)
2 0.67 3.0
(0.3-10.9)
20 . 4 74 . 2
(0.4-15.6)
Total (9662) 34814 14 2.18 6.4
(3.5-10.8)
17 7.31 2.3
(1.4-3.7)
12 4.01 3.0
(1.5-5.2)
SMR = Standardized mortality ratio; PY = Person Years; Obs = Observed; Exp = Expected; CI = Confidence interval
A I D S  c a s e s .  U n d e r s t a n d i n g  t h e  c a u s e s  o f  s u c h  a u g -
mented risks will help reduce mortality from non-AIDS
defining illnesses. In this perspective, anti-smoking cam-
paigns may be crucial in making antiretroviral treatments
more effective.
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